IMNM logo

IMNM

Immunome Inc.

$9.51
-$0.39(-3.94%)
44
Overall
--
Value
63
Tech
26
Quality
Market Cap
$884.38M
Volume
684.06K
52W Range
$5.15 - $16.73
Target Price
$23.67
Order:

Income Statement

MetricTrendChart
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
------$14.0M$9.0M
Total Revenue
------$14.0M$9.0M
GROSS PROFIT
Gross Profit
------$14.0M$9.0M
OPERATING EXPENSES
Operating Expenses
$12.3M$25.2M$36.9M$123.5M$314.8M
Research & Development
$7.5M$14.1M$23.3M$23.1M$129.5M
Research Expense
$7.5M$14.1M$23.3M$23.1M$129.5M
Selling, General & Administrative
$4.8M$11.1M$13.6M$19.7M$33.0M
Selling & Marketing Expenses
----$622.0K----
General & Administrative Expenses
$4.8M$11.1M$13.6M$19.7M$33.0M
Depreciation & Amortization
$800.0K$800.0K$400.0K$500.0K$1.6M
Depreciation & Amortization
$800.0K$800.0K$400.0K----
OPERATING INCOME
Operating income
$-12.3M$-25.2M$-36.9M$-109.5M$-305.8M
EBITDA
$-17.0M$-24.4M$-36.3M$-108.8M$-303.7M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$38.0K$10.0K$-5.0K$-2.7M$-12.8M
Interest Income Operating
$1.0K--------
Net Non-Operating Interest Income/Expense
$-38.0K$-10.0K$5.0K$2.7M$12.8M
Other Income/Expense
$5.5M$-503.0K--$-80.8M--
Other Special Charges
$-5.5M$503.0K------
SPECIAL ITEMS
Special Income Charges
----$-622.0K----
PRE-TAX INCOME
EBIT
$-17.8M$-25.2M$-36.9M$-109.5M$-305.8M
Pre-Tax Income
$-17.8M$-24.7M$-36.9M$-26.0M$-293.0M
NET INCOME
Net Income
$-17.8M$-24.7M$-36.9M$-106.8M$-293.0M
Net Income (Continuing Operations)
$-17.8M$-24.7M$-36.9M$-106.8M$-293.0M
Net Income (Discontinued Operations)
$-17.8M$-24.7M$-36.9M$-106.8M$-293.0M
Net Income (Common Stockholders)
$-17.8M$-24.7M$-37.5M$-106.8M$-293.0M
TOTALS
Total Expenses
$12.3M$25.2M$36.9M$123.5M$314.8M
SHARE & EPS DATA
Average Shares Outstanding
$3.4M$11.5M$12.1M$19.8M$58.6M
Average Shares Outstanding (Diluted)
$3.4M$11.5M$12.1M$19.8M$58.6M
Shares Outstanding
$10.7M$12.1M$12.2M$87.0M$87.0M
Basic EPS
$-5.26$-2.14$-3.09$-5.38$-5
Basic EPS (Continuing Operations)
$-5.26$-2.14$-3.09$-5.38$-5
Diluted EPS
$-5.26$-2.14$-3.09$-5.38$-5
Diluted EPS (Continuing Operations)
--$-2.14$-3.09$-5.38$-5
OTHER METRICS
Non Recurring Operation Expense
----$622.0K----
Other Gand A
$4.8M$11.1M$13.6M$19.7M$33.0M
Rent And Landing Fees
$-400.0K$-500.0K------
Selling Expense
----$622.0K----

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2IMNM$9.51-3.9%684.06K
3
4
5
6

Get Immunome Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.